Chun-sheng Kang

Key Laboratory Of Post Neuro Injury Neuro Repair And Regeneration In Central Nervous System
Tianjin, 300052, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 50 publications

Pharmacological induction of mitochondria-lysosome hyper-tethering elicits synthetic lethality in glioblastoma.

Pharmacological induction of mitochondria-lysosome hyper-tethering elicits synthetic lethality in glioblastoma.

Journal: Cancer letters

Published: January 29, 2026

AQB improves carboplatin sensitivity in endometrial cancer through dual DNA repair modulation: suppression of the p21-E2F1-RAD51 and ATF3-HDAC1-BRCA1 signaling.

AQB improves carboplatin sensitivity in endometrial cancer through dual DNA repair modulation: suppression of the p21-E2F1-RAD51 and ATF3-HDAC1-BRCA1 signaling.

Journal: Cell death & disease

Published: February 22, 2025

EPIC-1042 alleviates cerebral ischemic/reperfusion injury through TAX1BP1-induced mitophagy.

EPIC-1042 alleviates cerebral ischemic/reperfusion injury through TAX1BP1-induced mitophagy.

Journal: Free radical biology & medicine

Published: January 09, 2025

CYP3A5 promotes glioblastoma stemness and chemoresistance through fine-tuning NAD+/NADH ratio.

CYP3A5 promotes glioblastoma stemness and chemoresistance through fine-tuning NAD+/NADH ratio.

Journal: Journal of experimental & clinical cancer research : CR

Published: September 20, 2024

RUNX1/NPM1/H3K4me3 complex contributes to extracellular matrix remodeling via enhancing FOSL2 transcriptional activation in glioblastoma.

RUNX1/NPM1/H3K4me3 complex contributes to extracellular matrix remodeling via enhancing FOSL2 transcriptional activation in glioblastoma.

Journal: Cell death & disease

Published: October 07, 2023

EPIC-0628 abrogates HOTAIR/EZH2 interaction and enhances the temozolomide efficacy via promoting ATF3 expression and inhibiting DNA damage repair in glioblastoma.

EPIC-0628 abrogates HOTAIR/EZH2 interaction and enhances the temozolomide efficacy via promoting ATF3 expression and inhibiting DNA damage repair in glioblastoma.

Journal: Cancer letters

Published: October 03, 2023

Compound AC1Q3QWB upregulates CDKN1A and SOX17 by interrupting the HOTAIR-EZH2 interaction and enhances the efficacy of tazemetostat in endometrial cancer.

Compound AC1Q3QWB upregulates CDKN1A and SOX17 by interrupting the HOTAIR-EZH2 interaction and enhances the efficacy of tazemetostat in endometrial cancer.

Journal: Cancer letters

Published: July 12, 2023

L3MBTL1, a polycomb protein, promotes Osimertinib acquired resistance through epigenetic regulation of DNA damage response in lung adenocarcinoma.

L3MBTL1, a polycomb protein, promotes Osimertinib acquired resistance through epigenetic regulation of DNA damage response in lung adenocarcinoma.

Journal: Cell death & disease

Published: April 10, 2023

MUC1 promotes glioblastoma progression and TMZ resistance by stabilizing EGFRvIII.

MUC1 promotes glioblastoma progression and TMZ resistance by stabilizing EGFRvIII.

Journal: Pharmacological research

Published: October 07, 2022

Engineering Lipusu with lysophosphatidylcholine for improved tumor cellular uptake and anticancer efficacy.

Engineering Lipusu with lysophosphatidylcholine for improved tumor cellular uptake and anticancer efficacy.

Journal: Journal of materials chemistry. B

Published: February 25, 2022

Combination LSD1 and HOTAIR-EZH2 inhibition disrupts cell cycle processes and induces apoptosis in glioblastoma cells.

Combination LSD1 and HOTAIR-EZH2 inhibition disrupts cell cycle processes and induces apoptosis in glioblastoma cells.

Journal: Pharmacological research

Published: March 28, 2021

Virus-like nanoparticle as a co-delivery system to enhance efficacy of CRISPR/Cas9-based cancer immunotherapy.

Virus-like nanoparticle as a co-delivery system to enhance efficacy of CRISPR/Cas9-based cancer immunotherapy.

Journal: Biomaterials

Published: June 11, 2020

Showing 1-12 of 50

Last Updated: 09/26/2026